76
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Prostate-specific antigen and its derivatives in young adults occupationally exposed to quarry pollutants in southeastern Nigeria

, , , , , & show all
Pages 258-263 | Received 20 Oct 2015, Accepted 24 Jun 2016, Published online: 29 Jul 2016

References

  • Parent MÉ, Goldberg MS, Crouse DL, et al. Traffic-related air pollution and prostate cancer risk: a case-control study in Montreal, Canada. Occup Environ Med. 2013;70:511–518.
  • Shim SR, Kim JH, Song YS, Lee WJ. Association between air pollution and benign prostatic hyperplasia: an ecological study. Arch Environ Occup Health. 2015. doi:1080/19338244.2015.1093458.
  • Goldberg MS, Semiatyck J, DeWar R, Desy M, Riberdy H. Risk of developing cancer relative to living near a municipal solid waste landfill site in Montreal, Quebec, Canada. Arch Environ Health. 1999;54:291–296.
  • Rotkin ID. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treatment Rep. 1977;24:486–494.
  • Seidler A, Heiskel H, Bickeboller R, Elsner G. Association between diesel exposure at work and prostate cancer. Scand J Work Environ Health. 1998;24:486–494.
  • Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull. 2003;68:71–94.
  • Ukpong EC. Environmental impact of aggregate mining by crush rock industries in Akamkpa Local Government Area of Cross River State. Nigerian J Technol. 2012;31:128–138.
  • Olusegun O, Adeniyi A, Adeola GT. Impact of granite quarrying on the health of workers and nearby residents in Abeokuta, Ogun State, Nigeria. Ethiopian J Environ Stud Manage. 2009;2:1–11.
  • Maduka SO, Osim EE, Dimkpa U. Respiratory symptoms and blood eosinophil level in workers exposed to quarry dust in South-Eastern Nigeria. J Environ Occup Sci. 2014;3:175–180.
  • Oxman AD, Muir DCF, Shannon HS, Stock SR, Hnizdo E, Lange HJ. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic review. Am Rev Respir Dis. 1993;148:38–48.
  • Medical Research Council. Respiratory Symptoms Questionnaire. London, England: British Medical Research Council; 1986.
  • Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine: Environmental Lung Diseases. 16th ed. New York, NY: McGraw-Hill; 2008;1521–1527.
  • Urom SE, Antai AB, Osim EE. Symptoms and lung function values in Nigerian men and women exposed to dust generated from crushing of granite rocks in Calabar, Nigeria. Niger J Physiol Sci. 2004;19:41–47.
  • National Cancer Institute. Prostate specific antigen test. http://www.cancer.gov/types/prostate/psa-fact-sheet. Reviewed 2012. Accessed May 11, 2014.
  • Hoffman RM, Clannon DL, Littenberg B, Frank JJ, Pierce JC. Using the free to total prostate specific antigen ratio to detect prostate cancer in men with non-specific elevations of prostate specific antigen level. J Gen Intern Med. 2000;15:739–748.
  • Lilja H, Christensson A, Dahlén U, et al. Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem. 1991;37:1618–1625.
  • Stenman UH, Leinonen J, Alfthan H, et al. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51:222–226.
  • Lilja H. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer. Scand J Clin Lab Invest Suppl. 1995;220:47–56.
  • McCormack RT, Rittenhouse HG, Finlay JA, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995;45:729–744.
  • Vessella RL, Lange PH. Issues in the assessment of prostate-specific antigen immunoassays: an update. Urol Clin North Am. 1997;24:261–268.
  • Walz J, Haese A, Scattoni A, et al. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower. Cancer. 2008;113:2695–2703.
  • Demura H, Nakamura M, Hasumi H., et al. Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy. Int J Urol. 2004;11:494–500.
  • Mitrunen K, Pettersson K, Piironen T, et al. A novel dual-label one-step immunoassay for simultaneous measurement of free and total PSA concentrations and ratios in serum. Clin Chem. 1995;41:1115–1120.
  • Catalona WJ, Smith DS, Ratliff TL. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–1161.
  • Vashi AR, Oesterling JE. Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer. Mayo Clin Proc. 1997;72:337–344.
  • Catalona WJ. Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. Prostate Suppl. 1996;7:64–69.
  • Verma DK, Vacek PM, des Tombe K, et al. Silica exposure assessment in a mortality study of Vermont granite workers. J Occup Environ Hyg. 2011;8:71–79.
  • National Toxicology Program. NTP 12th report on carcinogens. Rep Carcinog. 2011;12:iii-499.
  • International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans. Arsenic, Metals, Fibres, and Dust. Lyon, France: International Agency for Research on Cancer; 2012. A Review of Human Carcinogens; vol. 100 C.
  • Occupational exposure to carcinogens. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-101/what-is-a-risk-factor/occupational-exposure/?region=on. Accessed October 30, 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.